Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients
Pediatric Dermatology · 2025-07 · 42 (4) · 796-799
DOI: 10.1111/pde.15882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Dermatology, online erschienen am 06.02.2025. Verfasst von Rahul Mahajan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Oral tofacitinib shows promise for pediatric alopecia areata (AA), but more data on its efficacy and safety are needed.
Methods
We analyzed 36 patients aged ≤ 16 years with moderate to severe AA (SALT score > 20) who received at least 6 months of oral tofacitinib.
Results
SALT75 was achieved in 72.2% (26/36) and SALT100 in 52.8% (19/36) within 4.1 ± 1.7 and 6.7 ± 2.8 months, respectively; 27.8% (10/36) were non‐responders. Nine patients had adverse events, with two requiring treatment discontinuation.
Conclusion
Tofacitinib is effective for pediatric AA, with rapid regrowth in responders. The durability of benefit and need for long term maintenance therapy require further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Rahul Mahajan, Hitaishi Mehta
Zitieren
APA
Mahajan, R., Mehta, H., De, D., & Handa, S. (2025). Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients. Pediatric Dermatology, 42(4), 796-799. https://doi.org/10.1111/pde.15882
Vancouver
Mahajan R, Mehta H, De D, Handa S. Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients. Pediatric Dermatology. 2025;42(4):796-799. doi:10.1111/pde.15882
BibTeX
@article{Mahajan2025,
author = {Mahajan, Rahul and Mehta, Hitaishi and De, Dipankar and Handa, Sanjeev},
title = {Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients},
journal = {Pediatric Dermatology},
year = {2025},
volume = {42},
number = {4},
pages = {796--799},
doi = {10.1111/pde.15882}
}
EUVIMED